Search RTI Surgical

RTI Surgical^® to Present at the UBS 2019 Global Healthcare Conference in New York

May 14, 2019

Molly Poarch
Media and Investor Contact
mpoarch@rtix.com
+1 224 287 2661

Deerfield, Ill., May 14, 2019 -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced Camille Farhat, President and Chief Executive Officer, and Jonathon Singer, Chief Financial and Administrative Officer, are scheduled to present at the UBS Global Healthcare Conference on Monday, May 20, at the Grand Hyatt in New York at 8:00 a.m. EDT.

A live audio webcast of the conference presentation will be available online through the investor relations page of the Company’s website at http://www.rtix.com. A replay of the webcast will be archived on the website for approximately 90 days.

About RTI Surgical Holdings, Inc.

RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic and trauma procedures and are distributed in nearly 50 countries. RTI has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com. Connect with us on LinkedIn and Twitter.